Peptide Research Profile
Ultima-Hexarelin 5mg is a synthetic growth hormone releasing peptide (GHRP-6 analogue) manufactured by Ultima Peptides for advanced laboratory research. This hexapeptide belongs to the growth hormone secretagogue family and represents a powerful research tool for investigating the hypothalamic-pituitary-growth hormone axis in controlled experimental conditions. Researchers studying endocrinological pathways and growth factor signalling mechanisms frequently examine this peptide in cellular and tissue models.
The compound demonstrates high affinity for ghrelin receptors and exhibits potent growth hormone release properties in preclinical research models. Laboratory investigations have explored its interaction with specific receptor subtypes and downstream signalling cascades involved in growth hormone regulation. Research scientists at Stroid UK Shop can access this peptide for comprehensive studies examining neuroendocrine function and metabolic pathway modulation.
Laboratory Applications
Research applications for Ultima-Hexarelin encompass diverse areas of biological investigation. Endocrinologists study its effects on pituitary cell cultures to understand growth hormone release mechanisms and receptor pharmacology. The peptide serves as a valuable comparator in peptide research examining different secretagogue potencies and selectivity profiles. Cellular biologists investigate its influence on intracellular calcium mobilisation and cAMP signalling pathways in vitro.
Metabolic research laboratories utilise this compound to examine growth hormone-mediated effects on protein synthesis, lipolysis, and carbohydrate metabolism in tissue preparations. The peptide’s stability profile makes it suitable for extended incubation studies and dose-response curve generation. Research teams investigating growth hormone resistance syndromes analyse receptor binding kinetics using this standardised research tool. Comparative studies often examine Ultima-Hexarelin alongside other growth hormone releasing compounds available through SARMS research collections.
Technical Specifications
| Parameter | Specification |
|---|---|
| Molecular Formula | Verify with supplier |
| Molecular Weight | Verify with supplier |
| CAS Registry | Verify with supplier |
| Purity | Verify with supplier |
| Form | Lyophilised powder |
| Storage | -20°C, dry conditions |
| Solubility | Water, saline solutions |
| Research Grade | Laboratory use only |
Storage protocols require maintaining the lyophilised peptide at -20°C in sealed containers with desiccant protection. Reconstituted solutions should be prepared fresh for each experiment using sterile water or appropriate buffer systems. Researchers should verify analytical specifications through hexarelin peptide documentation before initiating experimental procedures.
Research Compliance
Ultima-Hexarelin 5mg is manufactured exclusively for laboratory research purposes and in-vitro applications. This product is not intended for human consumption, therapeutic use, or clinical applications. Researchers must ensure proper laboratory protocols, safety procedures, and regulatory compliance when handling this research peptide. All experimental work should be conducted under appropriate institutional oversight and ethical guidelines for peptide research.
